Drug interactions for the following drug(s)
Applies to: gabapentin 300 MG Oral Capsule <> gabapentin 300 MG Oral Capsule
The risk or severity of adverse effects can be increased when Gabapentin is combined with gabapentin enacarbil.
Applies to: gabapentin 300 MG Oral Capsule <> Lyrica 75 MG Oral Capsule
The risk or severity of adverse effects can be increased when Pregabalin is combined with Gabapentin.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.
Applies to: gabapentin 300 MG Oral Capsule <> gabapentin 300 MG Oral Capsule
Drug1 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug1 is resolved to gabapentin, Drug2 is resolved to gabapentin enacarbil and interaction asserted in DrugBank between Gabapentin and Gabapentin Enacarbil. Drug1 is resolved to gabapentin enacarbil, Drug2 is resolved to gabapentin and interaction asserted in DrugBank between Gabapentin Enacarbil and Gabapentin.
Applies to: gabapentin 300 MG Oral Capsule <> Lyrica 75 MG Oral Capsule
Drug1 (rxcui = 310431, name = gabapentin 300 MG Oral Capsule, tty = SCD). Drug2 (rxcui = 607038, name = pregabalin 75 MG Oral Capsule [Lyrica], tty = SBD). Drug1 is resolved to gabapentin, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Gabapentin and Pregabalin. Drug1 is resolved to gabapentin enacarbil, Drug2 is resolved to pregabalin and interaction asserted in DrugBank between Gabapentin Enacarbil and Pregabalin.
Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.